Xencor Inc — Director's Dealing 2018

Aug 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xencor Inc (XNCR)
CIK: 0001326732
Period of Report: 2018-08-14

Reporting Person: Foster Paul A (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-14	Common Stock	M	15496	$11.05	Acquired	20448	Direct
2018-08-14	Common Stock	S	15496	$41.1061	Disposed	4952	Direct
2018-08-15	Common Stock	M	106	$11.05	Acquired	5058	Direct
2018-08-15	Common Stock	S	106	$41.10	Disposed	4952	Direct
2018-08-16	Common Stock	M	20739	$11.05	Acquired	25691	Direct
2018-08-16	Common Stock	S	20739	$41.10	Disposed	4952	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-14	Stock Option (right to buy)	$11.05	M	15496	Disposed	2024-02-20	Common Stock (15496)	Direct
2018-08-15	Stock Option (right to buy)	$11.05	M	106	Disposed	2024-02-20	Common Stock (106)	Direct
2018-08-16	Stock Option (right to buy)	$11.05	M	20739	Disposed	2024-02-20	Common Stock (20739)	Direct

Footnotes

F1: Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,207 shares of Common Stock acquired on June 10, 2015, 1,212 shares of Common Stock acquired on December 10, 2015 and 114 shares of Common Stock acquired on June 9, 2018.

F2: The weighted average sale price for the transaction reported was $41.1061, and the range of prices were between $41.10 and $41.120. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3: The stock option is fully vested.